Your browser doesn't support javascript.
loading
Risk of herpes zoster following mRNA COVID-19 vaccine administration.
Florea, Ana; Wu, Jun; Qian, Lei; Lewin, Bruno; Sy, Lina S; Lin, I-Chun; Ku, Jennifer H; Tseng, Hung Fu.
Afiliação
  • Florea A; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
  • Wu J; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
  • Qian L; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
  • Lewin B; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
  • Sy LS; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
  • Lin IC; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
  • Ku JH; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
  • Tseng HF; Kaiser Permanente Southern California, Department of Research & Evaluation, Pasadena, CA, USA.
Expert Rev Vaccines ; 22(1): 643-649, 2023.
Article em En | MEDLINE | ID: mdl-37416973
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina contra Herpes Zoster / Vacinas contra COVID-19 / COVID-19 / Herpes Zoster Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina contra Herpes Zoster / Vacinas contra COVID-19 / COVID-19 / Herpes Zoster Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article